Sildenafil

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9497 publications

Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report.

Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report.

Journal: Journal of drugs in dermatology : JDD

Published: September 04, 2026

Effects of Gualou Xiebai Banxia Decoction on pulmonary vascular remodeling in rats with hypoxic pulmonary hypertension

Effects of Gualou Xiebai Banxia Decoction on pulmonary vascular remodeling in rats with hypoxic pulmonary hypertension

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: September 03, 2026

Use of Oral Sildenafil in the Management of Persistent Pulmonary Hypertension of the Newborn: A Case Report and Review of Literature.

Use of Oral Sildenafil in the Management of Persistent Pulmonary Hypertension of the Newborn: A Case Report and Review of Literature.

Journal: Nigerian medical journal : journal of the Nigeria Medical Association

Published: August 03, 2026

Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.

Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.

Journal: EULAR rheumatology open

Published: August 01, 2026

Delayed conception or sildenafil prevents endothelial dysfunction in pregnant rats after renal ischemia-reperfusion.

Delayed conception or sildenafil prevents endothelial dysfunction in pregnant rats after renal ischemia-reperfusion.

Journal: American journal of physiology. Renal physiology

Published: July 30, 2026

An open-label, single-dose, randomized, parallel-group study of the safety and relative bioavailability of topical sildenafil cream vs oral sildenafil in healthy male adults.

An open-label, single-dose, randomized, parallel-group study of the safety and relative bioavailability of topical sildenafil cream vs oral sildenafil in healthy male adults.

Journal: Sexual medicine

Published: July 29, 2026

The Silent Threat: Unmasking Combined Post- and Pre-capillary Pulmonary Hypertension (CpcPH) in an Elderly Patient With Heart Failure With Preserved Ejection Fraction (HFpEF).

The Silent Threat: Unmasking Combined Post- and Pre-capillary Pulmonary Hypertension (CpcPH) in an Elderly Patient With Heart Failure With Preserved Ejection Fraction (HFpEF).

Journal: Cureus

Published: July 22, 2026

Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized Trials.

Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized Trials.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2026

Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized Trials.

Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized Trials.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2026

Bibliometric and Two-Sample Mendelian Randomization Analyses of the Causal Relationship Between Hypertension and Erectile Dysfunction.

Bibliometric and Two-Sample Mendelian Randomization Analyses of the Causal Relationship Between Hypertension and Erectile Dysfunction.

Journal: Journal of visualized experiments : JoVE

Published: July 13, 2026

Sildenafil Positivity and Chronic Cardiac Pathology in Men Who Died of Ischemic Heart Disease: An Age- and Sex-Matched Postmortem Case-Control Study.

Sildenafil Positivity and Chronic Cardiac Pathology in Men Who Died of Ischemic Heart Disease: An Age- and Sex-Matched Postmortem Case-Control Study.

Journal: Diagnostics (Basel, Switzerland)

Published: July 09, 2026

Phosphodiesterase Type 5 Inhibitors as Chemical Hazards in Honey and Honey-Based Products.

Phosphodiesterase Type 5 Inhibitors as Chemical Hazards in Honey and Honey-Based Products.

Journal: Molecules (Basel, Switzerland)

Published: July 06, 2026

Showing 1-12 of 9,497

Last Updated: 09/19/2026